⏳ Fetching live dividend data...
Home › Calculator › VBIV Dividend Calculator 2026
VBI Vaccines Inc. · NASDAQ
Price: $0.07 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in VBIV → $2.640020910196144e+26M in 10 years · $21,999,472,803,600,316,000,000,000,000,000.00/month
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open VBIV position with:
Real after-tax yield depends on where you live and how you hold VBIV.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3062.79% | 3059.99% | $306,279 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2603.37% | 2600.57% | $260,337 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2450.23% | 2447.43% | $245,023 / yr |
| 🇬🇧 UK ISA | 0% | 3062.79% | 3059.99% | $306,279 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2794.80% | 2792.00% | $279,480 / yr |
| 🇨🇦 TFSA | 0% | 3062.79% | 3059.99% | $306,279 / yr |
| 🇨🇦 CA Taxable | 25% | 2297.09% | 2294.29% | $229,709 / yr |
| 🇦🇺 Super (pension) | 15% | 2603.37% | 2600.57% | $260,337 / yr |
| 🇦🇺 AU Taxable | 30% | 2143.95% | 2141.15% | $214,395 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2254.98% | 2252.18% | $225,498 / yr |
| 🇫🇷 FR Taxable | 30% | 2143.95% | 2141.15% | $214,395 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
VBIV pays quarterly — 4 times per year. Next ex-div: TBD.
How VBIV compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VBIV sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2023-07-27 | 35,000 | $1.30 | $45.5K | ||
| A-Award | 2023-07-27 | 35,000 | $1.30 | $45.5K | ||
| A-Award | 2023-07-27 | 70,000 | $1.30 | $91.0K | ||
| A-Award | 2023-07-27 | 35,000 | $1.30 | $45.5K | ||
| A-Award | 2023-07-27 | 52,500 | $1.30 | $68.3K | ||
| A-Award | 2023-07-27 | 35,000 | $1.30 | $45.5K | ||
| A-Award | 2023-07-27 | 52,500 | $1.30 | $68.3K | ||
| A-Award | 2023-07-27 | 52,500 | $1.30 | $68.3K | ||
| A-Award | 2023-07-27 | 52,500 | $1.30 | $68.3K | ||
| A-Award | 2023-07-27 | 52,500 | $1.30 | $68.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VBIV dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →